NEXGEL, INC. 8-K

What Happened
NexGel, Inc. announced it received a deficiency letter from the Nasdaq Listing Qualifications Department on April 22, 2026, notifying the company that its common stock has had a closing bid below Nasdaq’s $1.00 minimum for the last 30 consecutive business days. The notice does not affect trading immediately — NXGL continues to trade on The Nasdaq Capital Market — but Nasdaq has given NexGel 180 calendar days (until October 19, 2026) to regain compliance.

Key Details

• Date of notice: April 22, 2026.
• Deficiency: Closing bid price below $1.00 for 30 consecutive business days (violation of Nasdaq Listing Rule 5550(a)(2)).
• Compliance window: 180 days to regain compliance (deadline October 19, 2026); compliance is achieved if the bid closes at $1.00+ for 10 consecutive business days.
• If still noncompliant, Nasdaq may offer a second 180-day period provided NexGel meets market value and other initial listing standards (except the minimum bid price) and notifies Nasdaq of intent to cure — the company may need to effect a reverse stock split.
• Stock status: Continues trading under ticker “NXGL” while the compliance process proceeds.

Why It Matters
A continued failure to meet Nasdaq’s minimum bid price could lead to delisting, which would reduce liquidity and could materially affect the market for NexGel shares (potentially moving trading to less visible markets). NexGel may pursue measures such as a reverse stock split to raise its per-share price; such actions change share counts and can affect investor holdings. Investors should monitor the company’s stock price, any announced corrective actions, and subsequent filings for updates on the compliance process.